• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

GTH 2021 心脏手术最新技术:心脏手术中肝素诱导的血小板减少症的围手术期管理。

GTH 2021 State of the Art-Cardiac Surgery: The Perioperative Management of Heparin-Induced Thrombocytopenia in Cardiac Surgery.

机构信息

Department of Anesthesiology, Cardiothoracic and Vascular Anesthesia, Lausanne University Hospital (CHUV), Lausanne, Switzerland.

出版信息

Hamostaseologie. 2021 Feb;41(1):59-62. doi: 10.1055/a-1336-6116. Epub 2021 Feb 15.

DOI:10.1055/a-1336-6116
PMID:33588456
Abstract

Heparin-induced thrombocytopenia (HIT) is a severe, immune-mediated, adverse drug reaction that paradoxically induces a prothrombotic state. Particularly in the setting of cardiac surgery, where full anticoagulation is required during cardiopulmonary bypass, the management of HIT can be highly challenging, and requires a multidisciplinary approach. In this short review, the different perioperative strategies to run cardiopulmonary bypass will be summarized.

摘要

肝素诱导的血小板减少症(HIT)是一种严重的、免疫介导的药物不良反应,它会导致一种反常的血栓前状态。在心外科手术中,体外循环期间需要充分抗凝,HIT 的管理极具挑战性,需要多学科的方法。在这篇简短的综述中,我们将总结体外循环的不同围手术期策略。

相似文献

1
GTH 2021 State of the Art-Cardiac Surgery: The Perioperative Management of Heparin-Induced Thrombocytopenia in Cardiac Surgery.GTH 2021 心脏手术最新技术:心脏手术中肝素诱导的血小板减少症的围手术期管理。
Hamostaseologie. 2021 Feb;41(1):59-62. doi: 10.1055/a-1336-6116. Epub 2021 Feb 15.
2
How would we treat our own heparin-induced thrombocytopenia during cardiac surgery?在心脏手术期间,我们将如何治疗自身肝素诱导的血小板减少症?
J Cardiothorac Vasc Anesth. 2021 Jun;35(6):1585-1593. doi: 10.1053/j.jvca.2020.11.002. Epub 2020 Nov 5.
3
Management of refractory bleeding post-cardiopulmonary bypass in an acute heparin-induced thrombocytopenia type II renal failure patient who underwent urgent cardiac surgery with bivalirudin (Angiox) anticoagulation.一名急性II型肝素诱导的血小板减少症合并肾衰竭患者在接受使用比伐卢定(安其罗)抗凝的紧急心脏手术后,体外循环后难治性出血的管理。
Perfusion. 2018 Apr;33(3):235-240. doi: 10.1177/0267659117723457. Epub 2017 Aug 8.
4
Novel Use of Cangrelor With Heparin During Cardiopulmonary Bypass in Patients With Heparin-Induced Thrombocytopenia Who Require Cardiovascular Surgery: A Case Series.新型药物坎格雷洛联合肝素在需要心血管手术的肝素诱导血小板减少症患者体外循环中的应用:病例系列研究。
Semin Thorac Cardiovasc Surg. 2020;32(4):763-769. doi: 10.1053/j.semtcvs.2019.10.002. Epub 2019 Oct 11.
5
Heparin-induced thrombocytopenia: a frequent complication after cardiac surgery.肝素诱导的血小板减少症:心脏手术后常见的并发症。
Arch Mal Coeur Vaiss. 2007 Jun-Jul;100(6-7):563-8.
6
Heparin-Induced Thrombocytopenia and Cardiac Surgery.肝素诱导的血小板减少症与心脏手术。
Semin Thorac Cardiovasc Surg. 2019;31(3):335-344. doi: 10.1053/j.semtcvs.2018.10.011. Epub 2018 Nov 15.
7
Update on heparin-induced thrombocytopenia and cardiovascular interventions.肝素诱导的血小板减少症与心血管介入治疗的最新进展
Semin Hematol. 2005 Jul;42(3 Suppl 3):S22-7. doi: 10.1053/j.seminhematol.2005.05.014.
8
Heparin-induced thrombocytopenia.肝素诱导的血小板减少症。
Semin Cardiothorac Vasc Anesth. 2010 Mar;14(1):73-4. doi: 10.1177/1089253210362795.
9
[Argatroban, a new antithrombotic treatment for heparin-induced thrombocytopenia application in cardiac surgery and in intensive care].[阿加曲班,一种用于肝素诱导的血小板减少症的新型抗血栓治疗药物,应用于心脏手术和重症监护]
Ann Fr Anesth Reanim. 2014 Sep-Oct;33(9-10):514-23. doi: 10.1016/j.annfar.2014.06.006. Epub 2014 Aug 20.
10
Heparin-induced thrombocytopenia following cardiac surgery is associated with poor outcome.心脏手术后发生的肝素诱导的血小板减少症与不良预后相关。
J Cardiothorac Vasc Anesth. 2007 Feb;21(1):18-22. doi: 10.1053/j.jvca.2006.05.002. Epub 2006 Aug 23.

引用本文的文献

1
Long-term outcomes of heparin-induced thrombocytopenia after cardiac surgery.心脏手术后肝素诱导的血小板减少症的长期预后
JTCVS Open. 2024 Nov 10;23:190-198. doi: 10.1016/j.xjon.2024.10.029. eCollection 2025 Feb.